Lightspeed Venture Partners

Axonius Bolsters C-Suite with Strategic New Hires

Retrieved on: 
onsdag, maj 22, 2024
Diamond, CFO, Lightspeed Venture Partners, Software as a service, OneTrust, Senior, Customer, Growth, CMO, Workforce, Accel, Management

Following this, Axonius announced it raised $200M in a Series E extension round led by Accel and Lightspeed Venture Partners.

Key Points: 
  • Following this, Axonius announced it raised $200M in a Series E extension round led by Accel and Lightspeed Venture Partners.
  • The Axonius Correlated Partner Program also recently received its fourth consecutive 5-star rating in the CRN® Partner Program .
  • “We’re excited to have Wendy and Joe joining our team, and the timing couldn’t be better,” said Dean Sysman, CEO and Co-founder of Axonius.
  • “I’m thrilled to join Axonius at such a pivotal point in the company’s growth trajectory,” said Wendy Zheng, CFO of Axonius.

Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital

Retrieved on: 
tisdag, april 30, 2024
Oncology, Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Doctor of Philosophy, Lightspeed Venture Partners, Tissue, Avalon Rare Metals, CIO, Therapy, Investment, Pharmaceutical industry

Enlaza Therapeutics , the first covalent biologic platform company, today announced a $100 million Series A financing.

Key Points: 
  • Enlaza Therapeutics , the first covalent biologic platform company, today announced a $100 million Series A financing.
  • The financing was led by the Life Sciences group of J.P. Morgan Asset Management’s Private Capital division, with participation from existing investors: Frazier Life Sciences, Avalon Ventures, Lightspeed Venture Partners, and Samsara BioCapital.
  • The financing also includes new investors: Amgen Ventures, Regeneron Ventures, Bregua Corporation, Pappas Capital, and Alexandria Venture Investments.
  • Concurrent with the financing, Stephen Squinto, Ph.D., Chief Investment Officer (CIO) of the Life Sciences group of J.P. Morgan Private Capital, was named to the Board of Directors.

beehiiv raises $33M Series B for newsletter and email platform      

Retrieved on: 
tisdag, april 30, 2024
Marketing, Digital Marketing, Communications, Technology, Other Technology, Other Communications, Internet, Lightspeed Venture Partners, Betterment, HubSpot, NEA, Engineering, Monday.com, Acquisition, Arnold Schwarzenegger, Advertising, Series, Growth, Brex, Video game

beehiiv Inc., a next-generation email newsletter platform, today is announcing its $33M Series B led by NEA and participating investors including Sapphire Sport.

Key Points: 
  • beehiiv Inc., a next-generation email newsletter platform, today is announcing its $33M Series B led by NEA and participating investors including Sapphire Sport.
  • Since launching in 2021, beehiiv has seen rapid adoption, with current monthly revenue exceeding $1M, and over 1 billion emails dispatched monthly.
  • The funding will be allocated towards bolstering the engineering and support teams to improve the overall capabilities and user experience of the platform.
  • We’re thrilled to partner with them to establish beehiiv as the leading email platform for creators and advertisers alike.”

Augment Inc. Raises $227 Million at $977 Million Valuation to Empower Software Teams With AI

Retrieved on: 
onsdag, april 24, 2024
Start-Up, Professional Services, Technology, Artificial Intelligence, Software, Organization, Investment, Lightspeed Venture Partners, Mozilla, Gartner, Oracle WebLogic Server, Meta, Research, Intelligence, VMware, Engineering, IPO, Pure Storage, Microsoft, Eric Schmidt, BEA Systems, Snowflake, Speed of light, Meritech Capital Partners, Databricks, Sutter Hill Ventures, Growth, Yahoo!, Video game

This brings Augment’s total funding to $252 million, following its $25 million Series A led by Sutter Hill Ventures.

Key Points: 
  • This brings Augment’s total funding to $252 million, following its $25 million Series A led by Sutter Hill Ventures.
  • The company is founded by Igor Ostrovsky, former chief architect at Pure Storage and software engineer at Microsoft, and Guy Gur-Ari, an AI researcher who hails from Google.
  • Augment’s engineering team boasts deep AI and systems expertise, with alumni from Google, Meta, NVIDIA, Microsoft, Databricks, Snowflake, VMware and Pure Storage.
  • Lightspeed is thrilled to be joining Augment to help make the world's software better.”
    “Augment represents Sutter Hill Ventures’ first big bet on AI.

Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development

Retrieved on: 
onsdag, april 24, 2024
Data Management, Health, Technology, Artificial Intelligence, Pharmaceutical, Biotechnology, Ron Conway, Element, Biochemistry, ARCH Venture Partners, AI, Sequoia Capital, Systems biology, Intelligence, SVP, Medicine, Howard Hughes Medical Institute, Drug discovery, Onyx Pharmaceuticals, Food, EVP, R&D, Machine learning, Nobel Prize, NEA, Entrepreneurship, CIO, Boston Consulting Group, Therapy, Lux Capital, Foresite Capital, Executive, Lightspeed Venture Partners, Johnson & Johnson, Proteomics, Meta, Rockefeller University, Chemistry, Biology, Former, Drug development, Menlo Ventures, Interline, Stanford University, University, Food and Drug Administration, Disease, Patient, Senior advisor, Pharmaceutical industry

Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies.

Key Points: 
  • Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies.
  • Xaira brings together three core elements: advanced machine learning research, expansive data generation to power new models, and robust therapeutic product development.
  • With leading talent and capabilities in each area, Xaira is building a platform for drug discovery and development that will advance multiple drug programs and unlock biological understanding to inform future discovery.
  • Xaira is building significant AI research capabilities spanning fundamental computational methods development and their application to biological discovery, the design of drug-like matter, and clinical development.

Tabs Secures $7M in Seed Funding Led By Lightspeed to Advance its AI-powered B2B Accounts Receivable Platform

Retrieved on: 
torsdag, april 11, 2024
Software, Internet, Finance, Artificial Intelligence, Data Management, Accounting, Professional Services, Technology, Speed of light, Heart, Synovial joint, Lightspeed Venture Partners, Business, Growth, Cryptocurrency

Tabs, an Accounts Receivable (AR) platform for B2B businesses, today announced a $7 million seed funding round led by Lightspeed Venture Partners.

Key Points: 
  • Tabs, an Accounts Receivable (AR) platform for B2B businesses, today announced a $7 million seed funding round led by Lightspeed Venture Partners.
  • In fact, 55% of B2B invoices in the US are currently overdue, tying up trillions in capital for small and medium businesses.
  • At the heart of Tabs’ solution is Tabs AI, a proprietary platform built to understand and extract B2B contractual elements.
  • Tabs understands the complexity of modern B2B billing and has built the technology to centralize and streamline the entire process.

Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases

Retrieved on: 
onsdag, april 3, 2024
Hereditary hemorrhagic telangiectasia, Telangiectasia, Biotechnology, Blood, Disease, Atlas, Patient, Lung, Stroke, Viking Global Investors, Death, Artery, Chiari malformation, Rupture, Intraparenchymal hemorrhage, Heart failure, Lightspeed Venture Partners, Therapy, TGF, Antibody, Bleeding, Heart, Pharmacology, Unified school district, HHT, PAH, Atlas Venture, Pulmonary hypertension, Pharmaceutical industry

CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company pioneering a new approach to discovering and developing agonist antibodies, launched today with $128 million in financing. The Series A was co-led by BVF Partners and Atlas Venture, with participation from Lightspeed Venture Partners, RA Capital Management, Frazier Life Sciences, Viking Global Investors, Velosity Capital, and Checkpoint Capital. Diagonal was co-founded by Chief Executive Officer, Alex Lugovskoy, Ph.D., and Atlas and previously seeded by Atlas, Lightspeed Venture Partners, and Velosity Capital. The financing will support further advancement of the company’s proprietary DIAGONAL platform and pipeline of novel therapeutics to value-creating milestones, including its lead program for the treatment of hereditary hemorrhagic telangiectasia (HHT), a severely debilitating bleeding disorder with limited therapeutic options, through clinical proof-of-concept. Diagonal's agonist antibody activates a receptor complex in the TGF-β superfamily genetically impaired in HHT patients. In preclinical models of HHT, Diagonal's agonist antibodies prevent and reverse the formation of pathological vascular malformations.

Key Points: 
  • Diagonal was co-founded by Alex Lugovskoy, Ph.D., and Atlas and previously seeded by Atlas, Lightspeed Venture Partners, and Velosity Capital.
  • CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company pioneering a new approach to discovering and developing agonist antibodies, launched today with $128 million in financing.
  • Diagonal was co-founded by Chief Executive Officer, Alex Lugovskoy, Ph.D., and Atlas and previously seeded by Atlas, Lightspeed Venture Partners, and Velosity Capital.
  • In preclinical models of HHT, Diagonal's agonist antibodies prevent and reverse the formation of pathological vascular malformations.

Glean Appoints Tamar Yehoshua as President, Product and Technology to Accelerate Delivery of Enterprise AI Platform

Retrieved on: 
tisdag, mars 26, 2024
Software, Data Analytics, Artificial Intelligence, Data Management, Professional Services, Technology, Apps, Applications, Security, Microsoft, Organization, Pressure, Documentation, Citigroup, Software as a service, Growth, Data science, RAG, Knowledge, Meta, Research, Blog, Slack, ICONIQ, Lightspeed Venture Partners, Love, Ecosystem, Uber, IVP, Sequoia Capital, Sales

Glean , the AI-powered work assistant making waves among CIOs under pressure to quickly and securely deploy generative AI in the enterprise, announced Tamar Yehoshua as the company’s first President of Product and Technology, effective March 11.

Key Points: 
  • Glean , the AI-powered work assistant making waves among CIOs under pressure to quickly and securely deploy generative AI in the enterprise, announced Tamar Yehoshua as the company’s first President of Product and Technology, effective March 11.
  • She will oversee all of research and development, including global engineering, product, design, and data science, as Glean enters a period of rapid growth.
  • “Glean has seen tremendous growth over the last year as we help more and more companies bring secure, responsible generative AI into their organizations,” said Arvind Jain, co-founder and CEO of Glean.
  • “I loved working in venture capital, but the opportunity to lead product and technology at Glean was too good to pass up,” said Tamar Yehoshua.

Foundry Raises $80 Million in Seed and Series A Funding to Build a New Breed of Public Cloud

Retrieved on: 
torsdag, mars 21, 2024
Internet, Data Management, Technology, Artificial Intelligence, Software, Deep learning, Computational biology, GPU, LG, Speed of light, MIT, Databricks, Pear VC, AI, Stanford University, Conviction, Civilization, M12 (venture capital), Lightspeed Venture Partners, Ecosystem, NEA, KKR, Economics, Sequoia Capital

Today, Foundry , a new breed of public cloud for AI/ML workloads, announced $80M in seed and Series A funding to orchestrate the world’s compute capacity, rendering it universally accessible and useful.

Key Points: 
  • Today, Foundry , a new breed of public cloud for AI/ML workloads, announced $80M in seed and Series A funding to orchestrate the world’s compute capacity, rendering it universally accessible and useful.
  • Foundry is building to ensure humanity maximizes the utility of the computing power we already have, and will produce.
  • Foundry’s innovative methods are solving these issues by providing scalable GPU instances with unmatched price-performance ratios.
  • If you are interested in becoming a customer or partner, or joining the team, please visit the company’s website .

Big Sur AI raises $6.9M and launches an AI Sales Agent for E-commerce Merchants

Retrieved on: 
onsdag, mars 13, 2024
Online Retail, Retail, Technology, Software, Electronic Commerce, Artificial Intelligence, Speed of light, Entrepreneurship, Noise, Environment, CFO, Shopify, Meta, Google Shopping, AI, Android, Advertising, Lightspeed Venture Partners, CMO, Marketing, Online shopping

Today, Big Sur AI , an AI platform for e-commerce, announced a $6.9M seed round to democratize and simplify access to AI for retailers and brands.

Key Points: 
  • Today, Big Sur AI , an AI platform for e-commerce, announced a $6.9M seed round to democratize and simplify access to AI for retailers and brands.
  • Retail will be one of the biggest beneficiaries of AI transformation1 and Big Sur AI is dedicated to ensuring every merchant can easily tap into these benefits.
  • Big Sur AI is making that kind of customer relationship automatic.”
    The company’s AI Sales Agent, which is tailored for each merchant, is aimed at boosting merchants' sales through higher conversion rates and larger order sizes, while enabling shoppers to make well-informed purchase decisions effortlessly.
  • They saw firsthand the enormous opportunity to redefine the merchant and shopper experience for the AI era and started Big Sur AI to ensure that these advancements benefit all merchants.